Experiment 1175328

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE

Compounds isolated

SPARSOMYCIN

Alerts

RESULTS SIGNIFICANT AT P <0.001 LEVEL.DOSING ON DAYS 1,5 AND 9.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationZYLICZ,Z: WAGENER,DJT: VAN RENNES,H: WESSELS,JMC: VAN DER KLEIJN,E: DE GRIP,WJ: OTTENHEIJM,HCJ: VAN DEN BROEK,LAGM:. (1986). IN VIVO POTENTIATION OF CIS-DIAMMINEDICHLOROPLANTINUM (II) ANTITUMOR ACTIVITY BY PRETREATMENT WITH SPARSOMYCIN.. 32(1)
Amount utilized
Compound isolated
DiseasePOTENTIATED ACTIVITY OF CISPLATIN.
Dose amount0.5 MG
Number2
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE